News
Paper-based lateral flow immunoassays (LFIAs) are one of the most widely used point-of-care (PoC) devices; however, their application in early disease diagnostics is often limited due to insufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results